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Altered reactivity to norepinephrine through COX-2 induction by
vascular injury in hypercholesterolemic rabbits
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Although long term use of cyclooxygenase (COX)-2 inhibitors may be asso-
ciated with increased cardiovascular risk, their effects on vascular reactivity in
atherosclerosis has remained largely unexplored. The aim of the present study
was to evaluate the role of COX-2 induced by an atherosclerotic process, in the
local control of vascular tone. To this end, New Zealand White rabbits were fed
0.3% cholesterol for 3 weeks before being subjected to balloon injury of the
abdominal aorta. After another 2 weeks, the aorta was removed and used for
organ bath experiments and immunohistochemistry, and the prostaglandins
released were measured using enzyme immunoassays. Hypercholesterolemia
and vascular injury significantly increased the thickness of the intimal layer,
which was associated with an induction of COX-2 immunoreactivity throughout
the aortic wall. In these preparations, a significant decrease of the maximal con-
tractions induced by norepinephrine was observed: 89.3±12 mN in controls
(n=5) versus 67.6±13 mN in balloon injured aortas from hypercholesterolemic
rabbits (n=5); P<0,05. The norepinephrine-induced contractions of atheroscle-
rotic preparations were restored by the COX inhibitors DuP-697 (0.5 μmol/L)
and indomethacin (1.7 μmol/L), to similar contractions as was observed in aortic
preparations derived from healthy rabbits. Norepinephrine stimulation of the
abdominal aorta was accompanied by increased levels of prostaglandin I2 in ath-
erosclerotic (1,39±0,11 μg/mg, n=3) compared with normal aorta (0,53±0,17 μg/
mg, n=3, P<0,05). Selective COX-2 inhibition significantly decreased the pros-
taglandin I2 release from atherosclerotic aorta, but had no effect on the prostag-
landin release from aortic preparations derived from normal rabbits. These
observations suggest that the local induction of COX-2 during atherosclerosis
decreased the sensitivity to norepinephrine, and that COX-2 inhibitors may
locally increase vascular reactivity at sites of atherosclerotic lesions.
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Background: Paraoxonase (PON1), an enzyme closely associated with
high-density lipoproteins, appears to exert an important antioxidant effect by
removing lipid peroxidation products. PON1 may also play a role in the
pathogenesis of arterial thrombosis and atherosclerosis. The PON1 gene poly-
morphism involves a Gln → Arg interchange at codon 192 defined by a low-
activity isoform (Q allele) and a high-activity isoform (R allele) and has been
related in some studies to myocardial infarction (MI). The purpose of the
present study was to assess the relationship between PON1-192 polymor-
phism, and myocardial infarction in Tunisian population.
Material and method: A total of 303 Tunisian patients with MI and 408
healthy controls were included in the study. Diagnosis of MI was confirmed
according to the European Society of Cardiology criteria. The PON1-Q192R
genotypes were determined by polymerase chain reaction (PCR) amplification
and restriction analysis.
Results: The genotypes frequencies were in agreement with those pre-
dicted by the Hardy-Weinberg equilibrium in MI patients (X2=5.52;p=0.63)
and controls (X2=4.126; p=0.127). A significant difference in genotype distri-
bution and allele frequency was observed between patients and controls.
Patients with MI had a frequency of 17.1 % for RR genotype, 41.1% for the
QR genotype and 41.7% for the QQ genotype. The controls had a frequency
of only 10.9% for the RR genotype, 37.4% for the QR genotype and 51.6 %
for the RR genotype (X2=9.63, p=0.008). The MI patient group showed a sig-
nificantly higher frequency of R allele compared to controls (37.75%
vs. 29.55%; X2=10.74; p<0.001). In comparison to the QQ homozygotes, the
OR (95%CI) for MI was 1.35 (0.992-1.86) for QR heterozygotes and 1.93
(1.24-3.02) for RR homozygotes. In multivariate analysis, PON1-Q192R poly-
morphism is associated with MI (p=0.02). The other factors independently
associated with MI are age (p<0.001), cigarette smoking (p<0.001), hyper-
tension (p<0.02), diabetes mellitus (p<0.001) and dyslipidemia (p<0.01).
Conclusion: Our results show that PON1-192 polymorphism is indepen-
dently associated with myocardial infarction in our population.
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Chronic administration of N-acetylcysteine: impact on endothelial
dysfunction of epicardial coronary arteries associated with left ventri-
cular hypertrophy in a porcine model
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Claude Tardif, Michel Carrier, Louis P. Perrault
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The aim of this study was to investigate the potential effect of chronic admin-
istration of N-acetylcysteine (NAC), a thiol drug with antioxidant properties, on
the coronary endothelial dysfunction associated with LVH. Twenty-two 8-week-
old Landrace male swine were randomly divided into 4 experimental groups. The
control group (group 1) was submitted to a thoracotomy without aortic banding
(AB). The untreated aortic banded group (group 2) was kept for 60 days. The first
AB treated group (group 3) received 1000mg/day of NAC per os for 60 days
starting on the day of the surgery. The second AB treated group (group
4) received the same oral dose of NAC for 30 days starting on day 30. Hyper-
trophy was assessed by echocardiography. Coronary vascular reactivity was eval-
uated in organ chambers. Nitrite/nitrate ratio and glutathione levels were measured
to evaluate endothelial dysfunction. Finally, to assess oxidative stress, plasma lipid
hydroperoxide levels (LPO) were measured. The LV mass/ left ventricular dias-
tolic diameter ratio was significantly higher in group 2 (37.6±10.0 g/cm) compared
to group 1 (16.4±1.5 g/cm) confirming the development of LVH. This latest was
found to be associated with a significant endothelial dysfunction (maximal relax-
ation to serotonin 76±2% versus 85±3% for group 1 and 2 respectively; maximal
relaxation to bradykinin 100±0% versus 96±1% for group 1 and 2, respectively).
NAC did not prevent LVH development in group 3 (30.5±2.3 g/cm; p>0.05 versus
group 2) but attenuated its progression in group 4 (25.4±3.0 g/cm). Concentration
response curves to NAC showed improvement in endothelium-dependent relax-
ation to serotonin (55±2% and 57±3% for group 3 and 4, respectively) and to
bradykinin (99±1% and 99±1%). LPO levels were significantly lower in both
treated group as compared to group 2 (p<0.05). Both nitrite/nitrate ratio and glu-
tathione levels were significantly higher in both NAC treated groups compared to
group 2 (p<0.05). NAC supplementation demonstrated potent antioxidant proper-
ties in this porcine LVH model and may become a promising approach for the pre-
vention of coronary endothelial dysfunction.
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We wondered if Zucker obese (ZO) rats would be a good experimental
model to evaluate cardiovascular complications of Metabolic Syndrome (MS).
ZO rats were compared with both their littermate controls, Zucker lean (ZL) rats
and to Wistar rats (reference strain). We designed this work 1) to measure cer-
tain physical and biochemical characteristics of MS 2) to evaluate coronary and
cardiac function in isolated conditions and after ischemia 3) to study plasma and
heart tissue oxidative stress markers. In vivo, ZO rats had higher levels of
plasma glucose, cholesterol and triglycerides than their ZL littermates, but there
was no difference between the groups for systolic arterial blood pressure and
heart rate. In vitro, coronary endothelial function was notably impaired in ZO
and ZL rats. After global ischemia, the worse ventricular recovery in ZO and ZL
rats was associated with arrhythmias during reperfusion. We detected similar
levels of plasma ascorbyl free radical, Oxygen Radical Absorbance Capacity and
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vitamin C concentrations in the three groups. DHE staining showed higher
superoxide production in the coronary vessels of ZO rats than in ZL and Wistar
rats. Our results show that ZO might only correspond to early-stage cardiovas-
cular complications associated with MS.
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Alpha-sarcoglycanopathy (LGMD2D) is an autosomal recessive inherited
limb-girdle muscular dystrophy caused by mutations in the alpha-sarcoglycan
gene, SGCA. Disruption of SGCA gene in mouse (Sgca-null mouse) shares
many of clinical pictures observed in patients. Mice disclose progressive mus-
cular dystrophy. We sought to characterize cardiac function in this disease in
order to evaluate target therapy. After shaving, Sgca-null mice were anaesthe-
tized with isoflurane before performing echocardiography. Echocardiography
was performed with a Vevo 770 Visuals Sonics (30 MHz cardiac probe). Mice
were analysed at 5, 13, and 17 months.
Control and Sgca-null mice were similar regarding age and heart rate. At age
5 months, in Sgca-null mice, we found significant anatomical differences
regarding the inter-ventricular septal (IVS) wall thickness and the posterior wall
(PW) thickness, as compared to their control. The IVS diastolic thickness was
significantly increased in Sgca-null mice (0.91mm+/–0.06 vs 0.73 mm+/–0.02;
p=0.003). Furthermore, the PW diastolic thickness was also increased in Sgca-
null mice compared to WT (0.81mm+/–0.07 vs 0.69 mm+/–0.03; p=0.03). Also,
LV mass was significantly increased in Sgca-null mice (147mg+/–15 vs
117.6mg+/–5.3; p=0. 02). At age 13 months, LV mass was significantly higher
in Sgca-null mice (LV mass 205.22 mg vs 143 mg; p =0.001).The PW thickness
was significantly different in the 2 groups (0.89 mm in Sgca-null vs 0.73 mm;
p=0,02). Moreover, Sgca-null mice at 13 months disclosed dilatation of the left
ventricle (LVEDD: 4.84mm vs 4.29 mm; p= 0.019). Systolic function was con-
served in the 2 groups at 13 months regarding SF and EF.
At age 17 months, we noted a decreasing of the posterior wall thickening
(17% vs 30%; p= 0.036) and an increasing of the LV mass/weight (5.6 vs 3.9;
p=0,016). No significant differences were found regarding the other anatomic
echocardiography parameters.
This study is unique and provides data that will help researchers to evaluate
the efficiency of pharmaceutical or gene cardiac therapies.
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To evaluate the mechanisms and the impact of the ACE-inhibitor perin-
dopril (P) in a model of doxorubicin (D)- induced cardiotoxicity, male Wistar
rats received D (1mg/kg/d, i.p. for 10 days), P (2 mg/kg/d by gavage from day
1 to day 18), D (for 10 days) + P (for 18 days) or saline.
D decreased systolic blood pressure, body and heart weights. Left ventricular
diastolic diameter was increased by D (p<0.01) but it was not attenuated by P.
D decreased plasma vitamin C (p<0.05) and increased the ascorbyl radical/
vitamin C ratio (p<0.01). This ratio was attenuated by P. No difference was
found among groups in cTnI, BNP concentrations and tissue oxidative stress
(OS). Myocardial MCP-1 expression was higher in the D group. Cardiac kinin
receptor (B1R and B2R) expression was not affected by D yet binding sites for
B2R and B1R were increased in D+P and P groups, respectively (p<0.05).
In conclusion, D induced cardiac functional alterations, inflammation and
plasma OS whereas tissue OS, and cardiac kinin receptors expression were not
modified. P did not improve cardiac performance, but modulated kinin
receptor expression and enhanced antioxidant defense.
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Background: Tumor necrosis factor alpha (TNF-α) is a primary pro-
inflammatory cytokine expressed in adipocytes and plays a crucial role in the
inflammatory process, it also stimulates the production of chemo-attractant
cytokines which may be a key feature of atherosclerosis. Relationship between
polymorphisms in TNF-α gene and coronary heart disease has been reported,
but remains a controversial subject. The aim of our study was to investigate
the possible association between the -308 G/A promoter variant in the TNF-α
gene and myocardial infarction (MI) in a sample of Tunisian population.
Design and methods: Our study included 299 male patients MI enrolled
from the department of Cardiology at Rabta University Hospital of Tunis and
408 male volunteer subjects with no history of MI. Genomic DNA was
extracted from white blood cells, amplified by PCR followed by a digestion
with the appropriate restriction endonuclease (NcoI) and genotyped by electro-
phoresis in agarose gels. Statistical analyses were performed using SPSS 11.5.
Results: MI patients compared to controls had significantly higher preva-
lence of diabetes, hypertension, cigarette smoking and dyslipidemia (p
<0.001). The genotype frequencies were in agreement with those predicted by
the Hardy-Weinberg equilibrium in MI (X2=0.137, p=0.934) and control
groups (X2=0.10, p=0.951). In MI patients the genotype frequencies
were  63% for GG, 34.6% for GA and 2.5% for AA, and were 62.2% for GG,
34.8% for GA and 3.0% for AA in controls. No significant difference in gen-
otype and allele frequencies of the TNF-α –308G/A polymorphism were
detected between MI and control subjects. In both groups, analyses of variance
of lipid levels across –308G/A genotypes showed no significant difference.
Conclusion: Our findings revealed that the -308G/A polymorphism of
TNF-α gene is not a relevant marker of MI in the Tunisian population.
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Transient radial myocardial dysfunction in non ischemic segment
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Alexandre Bensaid, Laurens Mitchell-Heggs, Laurent Macron, Caroline
Dussault, Pascal Gueret, Pascal Lim
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Purpose: In some patients, extensive myocardial dysfunction may be
observed during acute coronary syndromes despite limited coronary lesions.
Mechanism of depressed contractility during ischemia in remote segments is
unclear. In the present study, we addressed the changes in myocardial defor-
mation in remote segments during acute experimental ischemia.
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